Facial scars are frequently deemed unpleasant and can profoundly impact a patient's psychological health. This study compares the effectiveness, safety, and capacity to speed up scar healing in the maxillofacial region between fractional carbon dioxide (CO₂) laser therapy alone and polydeoxyribonucleotide (PDRN) combined with CO₂ laser therapy.
Age Limitations: Participants must be between 18 and 50 years of age.
Recently cut wounds or surgical scars from about (1-6 months).
Consent to Participate: Willingness to provide informed consent and engage in all aspects of the study.
Pregnancy or breastfeeding at the time of study.
Known allergy to PDRN.
Isotretinoin.
Anticancer drugs.